Orfi L - Search Results

1

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter.

Ozvegy-Laczka C, Hegedus T, Várady G, Ujhelly O, Schuetz JD, Váradi A, Kéri G, Orfi L, Német K, Sarkadi B. Ozvegy-Laczka C, et al. Among authors: orfi l. Mol Pharmacol. 2004 Jun;65(6):1485-95. doi: 10.1124/mol.65.6.1485. Mol Pharmacol. 2004. PMID: 15155841

2

Relationship between lipophilicity and antitumor activity of molecule library of Mannich ketones determined by high-performance liquid chromatography, clogP calculation and cytotoxicity test.

Hollósy F, Lóránd T, Orfi L, Erös D, Kéri G, Idei M. Hollósy F, et al. Among authors: orfi l. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Mar 5;768(2):361-8. doi: 10.1016/s1570-0232(02)00004-1. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 11888064

3

Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1.

Hegedus T, Orfi L, Seprodi A, Váradi A, Sarkadi B, Kéri G. Hegedus T, et al. Among authors: orfi l. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):318-25. doi: 10.1016/s0925-4439(02)00095-9. Biochim Biophys Acta. 2002. PMID: 12084474 Free article. Review.

4

Evaluation of lipophilicity and antitumour activity of parallel carboxamide libraries.

Hollósy F, Seprödi J, Orfi L, Erös D, Kéri G, Idei M. Hollósy F, et al. Among authors: orfi l. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 25;780(2):355-63. doi: 10.1016/s1570-0232(02)00545-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12401362

5

Validation subset selections for extrapolation oriented QSPAR models.

Szántai-Kis C, Kövesdi I, Kéri G, Orfi L. Szántai-Kis C, et al. Among authors: orfi l. Mol Divers. 2003;7(1):37-43. doi: 10.1023/b:modi.0000006538.99122.00. Mol Divers. 2003. PMID: 14768902

6

Comparison of predictive ability of water solubility QSPR models generated by MLR, PLS and ANN methods.

Erös D, Kéri G, Kövesdi I, Szántai-Kis C, Mészáros G, Orfi L. Erös D, et al. Among authors: orfi l. Mini Rev Med Chem. 2004 Feb;4(2):167-77. doi: 10.2174/1389557043487466. Mini Rev Med Chem. 2004. PMID: 14965289

7

Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.

Blencke S, Zech B, Engkvist O, Greff Z, Orfi L, Horváth Z, Kéri G, Ullrich A, Daub H. Blencke S, et al. Among authors: orfi l. Chem Biol. 2004 May;11(5):691-701. doi: 10.1016/j.chembiol.2004.02.029. Chem Biol. 2004. PMID: 15157880

8

Improved, high yield synthesis of 3H-quinazolin-4-ones, the key intermediates of recently developed drugs.

Orfi L, Wáczek F, Pató J, Varga I, Hegymegi-Barakonyi B, Houghten RA, Kéri G. Orfi L, et al. Curr Med Chem. 2004 Oct;11(19):2549-53. doi: 10.2174/0929867043364423. Curr Med Chem. 2004. PMID: 15544462

9

Acid-base profiling of imatinib (gleevec) and its fragments.

Szakács Z, Béni S, Varga Z, Orfi L, Kéri G, Noszál B. Szakács Z, et al. Among authors: orfi l. J Med Chem. 2005 Jan 13;48(1):249-55. doi: 10.1021/jm049546c. J Med Chem. 2005. PMID: 15634018

10

Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.

Székelyhidi Z, Pató J, Wáczek F, Bánhegyi P, Hegymegi-Barakonyi B, Erös D, Mészáros G, Hollósy F, Hafenbradl D, Obert S, Klebl B, Kéri G, Orfi L. Székelyhidi Z, et al. Among authors: orfi l. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3241-6. doi: 10.1016/j.bmcl.2005.04.064. Bioorg Med Chem Lett. 2005. PMID: 15925511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters